Hypocaloric Nutrition in Critically Ill Patients (RuRaL)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01531335 |
Recruitment Status :
Completed
First Posted : February 10, 2012
Results First Posted : December 11, 2015
Last Update Posted : December 11, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Critically Ill | Dietary Supplement: Hypocaloric hyperproteic nutrition Dietary Supplement: Standard care | Phase 3 |
The research site will be the intensive care unit (ICU) of Hospital Universitario San Ignacio; eligible patients will >18 years of age with a presumed fasting period of at least 96 hours, with no contraindications for enteral nutrition. Patients with parenteral nutrition, pregnancy, diabetes, liver failure, renal failure, transplant protocol, or admitted from another hospital will be excluded. In all patients, the following information will be collected daily: enteral formula in ml, carbohydrate intake, insulin required (in IU), presence of hyper or hypoglicemia, presence of infections, among others.
The SOFA score will be assessed every two days until discharge from ICU.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 80 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Effectiveness of Hypocaloric Nutrition Compared With Standard Care in Critically Ill Adults Patients, a Randomized Controlled Trial |
Study Start Date : | August 2011 |
Actual Primary Completion Date : | August 2012 |
Actual Study Completion Date : | August 2012 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Standard care
Patients will receive normal nutritional regime of around 25 kcal per kg.
|
Dietary Supplement: Standard care
25 kcal per kg of body weight
Other Name: Isocaloric |
Experimental: Hypocaloric hyperproteic nutrition
15 kcal per kg of body weight and 1.7 grams of protein per kg
|
Dietary Supplement: Hypocaloric hyperproteic nutrition
15 kcal per kg of body weight and 1.7 grams of protein per kg.
Other Name: Hypocaloric hyperproteic |
- SOFA (Sequential Organ Failure Assessment) Score [ Time Frame: 48 hours since nutritional regime starts ]SOFA score evaluates six systems: respiratory, cardiovascular, coagulation, Central Nervous System, liver and renal. Each system gets a score from 0 (normal) to 4 (abnormal) and the sum of each score defines the final SOFA score, which 24 is the maximum score (high risk of morality) and 0 is the minimum score (low risk of mortality).
- Insulin Requirements [ Time Frame: Daily until day 21 or discharge from ICU ]This is an indirect measure of glycemic control, and is reported as a daily average.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- >18 years
- estimated fasting period of at least 96 hours
Exclusion Criteria:
- parenteral nutrition
- pregnancy
- diabetes
- liver or renal failure
- transplantation
- admitted from another hospital

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01531335
Colombia | |
Hospital Universitario San Ignacio | |
Bogota, DC, Colombia, 110311 |
Principal Investigator: | Saul Rugeles, MD | Pontificia Universidad Javeriana |
Responsible Party: | Lafrancol S.A. |
ClinicalTrials.gov Identifier: | NCT01531335 |
Other Study ID Numbers: |
SJ0079 |
First Posted: | February 10, 2012 Key Record Dates |
Results First Posted: | December 11, 2015 |
Last Update Posted: | December 11, 2015 |
Last Verified: | November 2015 |
adults |
Critical Illness Disease Attributes Pathologic Processes |